Mahendran Sekar

7.2k citations

205 papers · 5.0k indexed · 4 hit papers · h-index 38

Impact in

Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
Complementary and alternative medicine top 0.5%

Papers in

Toxicology 20
- Bioactive Compounds and Antitumor Agents 20
Complementary and alternative medicine 28
- Mangiferin and Mango Extracts 9

Co-authors: Neeraj Kumar Fuloria Vetriselvan Subramaniyan Shivkanya Fuloria Yuan Seng Wu Lowell E. Hokin Pei Teng Lum Siew Hua Gan Shrishailappa Badami
Journals: Frontiers in Pharmacology (9 papers)Molecules (8 papers)Drug Design Development and Therapy (6 papers)Polymers (5 papers)Journal of Biological Chemistry (4 papers)
Partner nations: Malaysia India Saudi Arabia

In The Last Decade

Mahendran Sekar

191 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

The Toxicity of Mercury and Its Chemical Compounds: Molecular Mechanisms and Environmental and Human Health Implications: A Comprehensive Review 2024 · 128 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 ACS Omega
2023 Frontiers in Immunology
2023 Environmental Chemistry Letters
2022 Frontiers in Pharmacology

Peers

Countries citing papers authored by Mahendran Sekar

Since Specialization

Citations

This map shows the geographic impact of Mahendran Sekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahendran Sekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahendran Sekar more than expected).

Fields of papers citing papers by Mahendran Sekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahendran Sekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahendran Sekar. The network helps show where Mahendran Sekar may publish in the future.

Co-authors

The 25 scholars most cited alongside Mahendran Sekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mahendran Sekar Line = papers co-authored together Mahendran Sekar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishing network pharmacology between natural polyphenols and Alzheimer’s disease using bioinformatic tools – An advancement in Alzheimer’s research Toxicology Reports ·Heesuk Lee, T. Tamilanban, Vetriselvan Subramaniyan, Mahendran Sekar, Vipin Kumar, Ashok Kumar Janakiraman, Saminathan Kayarohanam	2024	10
2	Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies Gilbert H. Sheinbaum, Н Д Каминская, Rhanye Mac Guad, Neeraj Kumar Fuloria, Vetriselvan Subramaniyan, Mahendran Sekar, Yuan Seng Wu	2024	2
3	Extraction, isolation, structural analysis, PPAR-γ binding studies & transactivation, glucose uptake, lipid lowering activity and in silico studies of Pterocarposide, Sabioside and Pterostilbene Journal of Molecular Structure ·Amy Delorenzo, H Pötzsch, Olivier Duron, Mahendran Sekar, Ashish Wadhwani, Jure Bosančić, B. R. Prashantha Kumar	2024	1
4	Unlocking the potential of Rosmarinic acid: A review on extraction, isolation, quantification, pharmacokinetics and pharmacology Phytomedicine Plus ·H Pötzsch, Amy Delorenzo, Olivier Duron, Mahendran Sekar, B. R. Prashantha Kumar	2024	3
5	Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer Cytokine ·Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Mahaveer Singh, E. D. Baldin, E. N. Olson, Neelima Kukreti, Dhanalekshmi Unnikrishnan Meenakshi, Neeraj Kumar Fuloria, Mahendran Sekar, Gaurav Gupta	2023	51
6	Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling Pathology - Research and Practice ·Md Sadique Hussain, Obaid Afzal, Gaurav Gupta, Abdulmalik Saleh Alfawaz Altamimi, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Neeraj Kumar Fuloria, Mahendran Sekar, Dhanalekshmi Unnikrishnan Meenakshi, Lakshmi Thangavelu, Ajay Sharma	2023	68
7	Plasma Modification Techniques for Natural Polymer-Based Drug Delivery Systems Pharmaceutics ·Roseanna Ryan, Edvania Torres A. Gomes, Vetriselvan Subramaniyan, Azah Mohd, Mahendran Sekar, Suresh V. Chinni, Gobinath Ramachawolran	2023	45
8	Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery Microorganisms ·Sabrina Vieira da Cunha, Yuan Seng Wu, Kalaivani Batumalaie, Rhanye Mac Guad, Ker Woon Choy, Ashok Kumar, (unknown), Md. Moklesur Rahman Sarker, Vetriselvan Subramaniyan, Mahendran Sekar, Neeraj Kumar Fuloria, Shivkanya Fuloria, Suresh V. Chinni, Gobinath Ramachawolran	2023	5
9	Antibacterial Potential of Bacopa monnieri (L.) Wettst. and Its Bioactive Molecules against Uropathogens—An In Silico Study to Identify Potential Lead Molecule(s) for the Development of New Drugs to Treat Urinary Tract Infections Molecules ·Jyoti Mehta, Jonathan Sturdivant, Shivkanya Fuloria, 東辻浩夫, Mahendran Sekar, Deeksha Salaria, Rajan Rolta, M. Yasmin Begum, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Kumarappan Chidambaram, Vetriselvan Subramaniyan, Kathiresan V. Sathasivam, Pei Teng Lum, Subasini Uthirapathy, Olatomide A. Fadare, Pyo Jung, Neeraj Kumar Fuloria	2022	30
10	Outer membrane vesicles as biomimetic vaccine carriers against infections and cancers Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology ·Nur Najihah Izzati Mat Rani, Young June You, Adeel Masood Butt, Sławomir Łapiński, Mahendran Sekar, Yusuke Sumi, Mohd Cairul Iqbal Mohd Amin	2022	12
11	A Review on DNA Vaccines in Pre-Clinical Trials Against SARS-CoV-2 Journal of Experimental Biology and Agricultural Sciences ·Sheeja T.S, Sinouvassane Djearamane, Shivkanya Fuloria, Saminathan Kayarohanam, Vetriselvan Subramaniyan, Mahendran Sekar, Neeraj Kumar Fuloria	2022	4
12	Chemistry, Biosynthesis and Pharmacology of Sarsasapogenin: A Potential Natural Steroid Molecule for New Drug Design, Development and Therapy Molecules ·Barbara Hardaway, Mahendran Sekar, Shivkanya Fuloria, M. Yasmin Begum, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Subban Ravi, Kumarappan Chidambaram, Vetriselvan Subramaniyan, Kathiresan V. Sathasivam, Srikanth Jeyabalan, Subasini Uthirapathy, Sivasankaran Ponnusankar, Pei Teng Lum, 山野葉子, Neeraj Kumar Fuloria	2022	22
13	COVID-19 Biomedical Plastics Wastes—Challenges and Strategies for Curbing the Environmental Disaster Sustainability ·Siddharthan Selvaraj, Somasundaram Prasadh, Shivkanya Fuloria, Vetriselvan Subramaniyan, Mahendran Sekar, M. Le Delliou, Belgacem Bouallègue, 洪宜芳, N. Yu. Turbina, Gero Ds, Kathiresan V. Sathasivam, Dhanalekshmi Unnikrishnan Meenakshi, Neeraj Kumar Fuloria	2022	5
14	Ten Commonly Available Medicinal Plants in Malaysia with Potential Sun Protection Factor and Antioxidant Properties – A Review Pharmacognosy Journal ·Sadananda Seshagiri, Herbert Baquerizo, Mahendran Sekar, Nur Najihah Izzati Mat Rani, Pei Teng Lum	2022	8
15	Pharmacognostical, Physicochemical and Phytochemical Evaluation of Strobilanthes kunthianus (Acanthaceae) Pharmacognosy Journal ·Vaysse Jérôme, Mahendran Sekar, Shrishailappa Badami	2020	8
16	Molecules of Interest – Karanjin – A Review Pharmacognosy Journal ·Д.В. Епишкин, Pinar Soysal, Pei Teng Lum, (unknown), Mohd. Farooq Shaikh, Mahendran Sekar	2020	13
17	Isolation and Structural Characterization of Phytoconstituents from Strobilanthes kunthianus ArticleView Pharmacognosy Journal ·Vaysse Jérôme, Mahendran Sekar, Subban Ravi, Shrishailappa Badami	2020	2
18	Resveratrol: Latest Scientific Evidences of its Chemical, Biological Activities and Therapeutic Potentials Pharmacognosy Journal ·Sungeun 김선근Kim, Mahendran Sekar, Siew Hua Gan, Pei Teng Lum, Jaishree Vaijanathappa, Subban Ravi	2020	14
19	FORMULATION AND EVALUATION OF AN INJECTABLE SOLUTION AS A DOSAGE FORM Journal of Drug Delivery and Therapeutics ·Yu. K. Gusak, Mahendran Sekar, 新华	2018	4
20	Land Use and Land Cover Mapping – Madurai District, Tamilnadu, India Using Remote Sensing and GIS Techniques International Journal of Civil and Structural Engineering ·S. Oishi, Joelson Moreira Mendes, D. Yuvaraj, Mahendran Sekar, Taciana Lago, M. Manivel, Arunachalam Thirunavukkarasu	2010	9

About Mahendran Sekar

Mahendran Sekar is a scholar working on Toxicology, Complementary and alternative medicine, Biochemistry, Pharmaceutical Science and Molecular Medicine, having authored 205 papers that have together received 5.0k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (20 papers), Natural Antidiabetic Agents Studies (14 papers), Phytochemicals and Antioxidant Activities (13 papers), Computational Drug Discovery Methods (12 papers), Essential Oils and Antimicrobial Activity (9 papers), Mangiferin and Mango Extracts (9 papers), Pancreatic function and diabetes (9 papers) and Medicinal Plant Research (7 papers). The work is most often cited by research in Toxicology (250 citations), Complementary and alternative medicine (412 citations), Molecular Medicine (223 citations), Biochemistry (236 citations) and Pollution (434 citations). Mahendran Sekar has collaborated with scholars based in Malaysia, India and Saudi Arabia. Frequent co-authors include Neeraj Kumar Fuloria, Vetriselvan Subramaniyan, Shivkanya Fuloria, Yuan Seng Wu, Lowell E. Hokin, Pei Teng Lum, Siew Hua Gan, Shrishailappa Badami, Nur Najihah Izzati Mat Rani and Kathiresan V. Sathasivam. Their work appears in journals such as Frontiers in Pharmacology, Molecules, Drug Design Development and Therapy, Polymers and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact